# Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh

> **NCT02531802** · PHASE1,PHASE2 · COMPLETED · sponsor: **PATH** · enrollment: 475 (actual)

## Conditions studied

- Escherichia Coli Diarrhea

## Interventions

- **BIOLOGICAL:** ETVAX
- **BIOLOGICAL:** dmLT
- **OTHER:** Bicarbonate Buffer

## Key facts

- **NCT ID:** NCT02531802
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-07-29
- **Final completion:** 2017-07-29
- **Target enrollment:** 475 (ACTUAL)
- **Last updated:** 2018-09-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02531802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02531802, "Enterotoxigenic Escherichia Coli (ETEC) ETVAX Vaccine Trial in Bangladesh". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02531802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*